These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8429746)

  • 1. [The T-lymphocyte. A hero or a villain in the drama?].
    Grunewald J; Wigzell H
    Lakartidningen; 1993 Jan; 90(3):149-50, 153. PubMed ID: 8429746
    [No Abstract]   [Full Text] [Related]  

  • 2. [The T cell receptor abnormalities and autoimmune diseases].
    Takeno M; Sakane T
    Tanpakushitsu Kakusan Koso; 1990 Apr; 35(5):865-73. PubMed ID: 2362962
    [No Abstract]   [Full Text] [Related]  

  • 3. Strategies for treating autoimmune disease with monoclonal antibodies.
    Wofsy D
    West J Med; 1985 Dec; 143(6):804-9. PubMed ID: 3911593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interleukin 2 receptor and its physiology. Implications for combatting autoimmune diseases and transplant rejections.
    Diamantstein T
    Behring Inst Mitt; 1987 Jun; (81):73-87. PubMed ID: 3115248
    [No Abstract]   [Full Text] [Related]  

  • 5. [HLA antigen genes and their clinical significance].
    Kikuchi I; Sasazuki T
    Rinsho Byori; 1985 Nov; 33 Spec No 65():160-73. PubMed ID: 3937922
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulatory/suppressor T cells in health and disease.
    Shevach EM
    Arthritis Rheum; 2004 Sep; 50(9):2721-4. PubMed ID: 15457438
    [No Abstract]   [Full Text] [Related]  

  • 7. New therapeutic approaches to autoimmune disease.
    Talal N
    Springer Semin Immunopathol; 1986; 9(1):105-16. PubMed ID: 2425440
    [No Abstract]   [Full Text] [Related]  

  • 8. Interleukin-2 receptor-targeted immune therapy.
    Diamantstein T; Hahn HJ
    Immunol Ser; 1993; 59():295-318. PubMed ID: 8461395
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-CD3 antibodies.
    Chatenoud L; Bach JF
    Immunol Ser; 1993; 59():175-91. PubMed ID: 8461387
    [No Abstract]   [Full Text] [Related]  

  • 10. Neonatal autoimmune disease: influence of CD4+ CD25+ regulatory T cells.
    Setiady YY; Agersborg S; Samy ET; Lewis JE; Tung KS
    Int Rev Immunol; 2005; 24(3-4):227-45. PubMed ID: 16036376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-class II antibody treatment in autoimmune diseases.
    Boitard C
    Immunol Ser; 1993; 59():279-93. PubMed ID: 8461393
    [No Abstract]   [Full Text] [Related]  

  • 12. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self.
    Sakaguchi S
    Nat Immunol; 2005 Apr; 6(4):345-52. PubMed ID: 15785760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of T cells in autoimmune uveitis.
    Becker MD; Adamus G; Davey MP; Rosenbaum JT
    Ocul Immunol Inflamm; 2000 Jun; 8(2):93-100. PubMed ID: 10980681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mouse immune response to human fibrinogen reveals an autoimmune component against mouse fibrinogen.
    Rubin B; Matron C
    Cell Immunol; 2005 Jan; 233(1):41-52. PubMed ID: 15876427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell activation in health and disease.
    Feldmann M
    Immunol Today; 1988 May; 9(5):121-4. PubMed ID: 3267172
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of monoclonal antibodies in vivo as a therapeutic strategy for alloimmune or autoimmune reactivity: the Besançon experience.
    Herve P; Racadot E; Wendling D; Rumbach L; Tiberghien P; Cahn JY; Flesch M; Wijdenes J
    Immunol Rev; 1992 Oct; 129():31-55. PubMed ID: 1464420
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunologic mechanisms in aplastic anemia. I. Introduction: Immunological system in aplastic anemia].
    Rupniewska ZM; Dmoszyńska-Giannopoulous A
    Przegl Lek; 1982; 39(9):607-11. PubMed ID: 6758055
    [No Abstract]   [Full Text] [Related]  

  • 18. CD4+CD25+ regulatory T cells: II. Origin, disease models and clinical aspects.
    Nielsen J; Holm TL; Claesson MH
    APMIS; 2004 Oct; 112(10):642-50. PubMed ID: 15601315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superagonistic anti-CD28 antibodies: potent activators of regulatory T cells for the therapy of autoimmune diseases.
    Beyersdorf N; Hanke T; Kerkau T; Hünig T
    Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv91-5. PubMed ID: 16239397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell-mediated maintenance of natural self-tolerance: its breakdown as a possible cause of various autoimmune diseases.
    Sakaguchi S; Toda M; Asano M; Itoh M; Morse SS; Sakaguchi N
    J Autoimmun; 1996 Apr; 9(2):211-20. PubMed ID: 8738965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.